Company Sector
APIs
APIs refers to active pharmaceutical ingredients, the core chemical or biologic substances used to make medicines. Companies in this category are typically exposed to manufacturing scale, supply reliability, and the economics of pharmaceutical production rather than a single branded asset story.
Why watch APIs
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest APIs news
The latest feed items from companies currently grouped under APIs.
- 01
- 02
TSHATaysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Source: Taysha Gene Therapies
- 03
TSHATaysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Source: Taysha Gene Therapies
- 04
- 05
- 06
- 07
RPIDRapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Source: Rapid Micro Biosystems
- 08
SNDXSyndax Announces Private Placement of $250.0 Million of Convertible Senior Notes
Source: Syndax Pharmaceuticals
- 09
IOVAIovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia
Source: Iovance Biotherapeutics, Inc.
- 10
- 11
IOVAIovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001
Source: Iovance Biotherapeutics, Inc.
- 12
SNDXSyndax to Host R&D Day Highlighting its Late-Stage Programs and Early-Stage Assets on July 14, 2026
Source: Syndax Pharmaceuticals
- 13
- 14
IOVAIovance Biotherapeutics to Present at Upcoming Conference
Source: Iovance Biotherapeutics, Inc.
- 15
SNDXSyndax Announces Participation in Upcoming Investor Conferences
Source: Syndax Pharmaceuticals
- 16
RPIDRapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering
Source: Rapid Micro Biosystems
- 17
RPIDRapid Micro Biosystems Reports First Quarter 2026 Financial Results
Source: Rapid Micro Biosystems
- 18
SNDXSyndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition
Source: Syndax Pharmaceuticals
- 19
IOVAIovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates
Source: Iovance Biotherapeutics, Inc.
- 20
RPIDRapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026
Source: Rapid Micro Biosystems
Companies in APIs
5 companies tagged with APIs.
Frequently Asked Questions
What does the APIs sector include?
APIs refers to active pharmaceutical ingredients, the core chemical or biologic substances used to make medicines. Companies in this category are typically exposed to manufacturing scale, supply reliability, and the economics of pharmaceutical production rather than a single branded asset story.
How many companies are currently tagged with APIs?
5 companies are currently grouped under APIs on BioPharmSignal.
Which companies are most visible in the APIs group right now?
ITCI, IOVA, RPID, SNDX are among the companies currently shown on this sector page.
How can I watch news for APIs?
Use the Watch button on this page to subscribe to APIs headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for APIs?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in APIs.